High-intensity exercise impairs extradiaphragmatic respiratory muscle perfusion in patients with COPD by Louvaris, Zafeiris et al.
Northumbria Research Link
Citation: Louvaris, Zafeiris, Rodrigues, Antenor, Dacha, Sauwaluk, Gojevic, Tin, Janssens,
Wim, Vogiatzis, Ioannis, Gosselink, Rik and Langer, Daniel (2021) High-intensity exercise
impairs extradiaphragmatic respiratory muscle perfusion in patients with COPD. Journal
of Applied Physiology, 130 (2). pp. 325-341. ISSN 8750-7587 
Published by: American Physiological Society
URL:  https://doi.org/10.1152/japplphysiol.00659.2020
<https://doi.org/10.1152/japplphysiol.00659.2020>
This  version  was  downloaded  from  Northumbria  Research  Link:
http://nrl.northumbria.ac.uk/id/eprint/44668/
Northumbria University has developed Northumbria Research Link (NRL) to enable users
to access the University’s research output. Copyright © and moral rights for items on
NRL are retained by the individual author(s) and/or other copyright owners.  Single copies
of full items can be reproduced, displayed or performed, and given to third parties in any
format or medium for personal research or study, educational, or not-for-profit purposes
without  prior  permission  or  charge,  provided  the  authors,  title  and  full  bibliographic
details are given, as well as a hyperlink and/or URL to the original metadata page. The
content must not be changed in any way. Full items must not be sold commercially in any
format or medium without formal permission of the copyright holder.  The full policy is
available online: http://nrl.northumbria.ac.uk/policies.html
This document may differ from the final, published version of the research and has been
made available online in accordance with publisher policies. To read and/or cite from the
published version of  the research,  please visit  the publisher’s website (a subscription
may be required.)
                        
1 
 
High-intensity exercise impairs  extradiaphragmatic 1 
respiratory muscle perfusion in patients with COPD 2 
 3 
Zafeiris Louvaris1,2, Antenor Rodrigues1,3,4, Sauwaluk Dacha1,5, Tin Gojevic1, 4 
Wim Janssens2, Ioannis Vogiatzis6, Rik Gosselink1,2 and Daniel Langer1,2 5 
 6 
1Faculty of Kinesiology and Rehabilitation Sciences, Department of Rehabilitation 7 
Sciences, Research Group for Rehabilitation in Internal Disorders, KU Leuven, 8 
Belgium 9 
2Clinical Department of Respiratory Diseases, UZ Leuven, BREATHE department 10 
CHROMETA, KU Leuven, Leuven, Belgium  11 
3Laboratory of Research in Respiratory Physiotherapy (LFIP), Department of 12 
Physiotherapy, Londrina State University (UEL), Londrina, Brazil 13 
4Research Aimed at Muscle Performance laboratory (RAMP). Department of Physical 14 
Therapy, University of Toronto, Toronto, Canada  15 
5Faculty of Associated Medical Sciences, Department of Physical Therapy, Chiang Mai 16 
University, Chiang Mai, Thailand 17 
6Department of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, 18 
Northumbria University Newcastle, United Kingdom 19 
 20 
 21 




Correspondence: Dr. Louvaris Zafeiris (zafeiris.louvaris@kuleuven.be) Rehabilitation 26 
and Respiratory Division, UZ Gasthuisberg, Herestraat 49, O&N4 Building, Bus 1510, 27 




News and Noteworthy 32 
 33 
Zafeiris Louvaris  29/9/20 13:32
Deleted: Strenuous34 
Zafeiris Louvaris  29/9/20 13:32
Deleted: interferes with35 
2 
 
We simultaneously assessed the blood flow index (BFI) in three respiratory muscles during 36 
hyperpnoea and high-intensity  constant-load cycling sustained at comparable levels of work of 37 
breathing and respiratory neural drive in patients with COPD. We demonstrated that high-38 
intensity exercise interferes with respiratory muscle perfusion as intercostal, scalene and 39 
abdominal BFI increased during hyperpnoea but not during cycling. Insufficient adjustment in 40 
respiratory muscle perfusion during exercise was associated with greater dyspnoea sensations 41 
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The study investigated whether high-intensity exercise interferes with inspiratory and 76 
expiratory muscle perfusion in patients with COPD. We compared respiratory local muscle 77 
perfusion between constant-load cycling (sustained at 80% WRpeak) and voluntary 78 
normocapnic hyperpnoea reproducing similar work of breathing (WoB) in 18 patients 79 
(FEV1:58±24% predicted). Local muscle blood flow index (BFI), using indocyanine green dye 80 
and fractional oxygen saturation (%StiO2) were simultaneously assessed by near-infrared 81 
spectroscopy (NIRS) over the intercostal, scalene, rectus abdominis and vastus lateralis 82 
muscles. Cardiac output (impedance cardiography), WoB (oesophageal/gastric balloon 83 
catheter), and diaphragmatic and extradiaphragmatic respiratory muscle electromyographic 84 
activity (EMG) were also assessed throughout cycling and hyperpnoea. Minute ventilation, 85 
breathing pattern, WoB and respiratory muscle EMG were comparable between cycling and 86 
hyperpnoea. During cycling, cardiac output and vastus lateralis BFI were significantly greater 87 
compared to hyperpnoea [by +4.2(2.6-5.9) L/min and +4.9(2.2-7.8) nmol/s], respectively, 88 
(p<0.01). Muscle BFI and %StiO2 were respectively lower during cycling compared to 89 
hyperpnoea in scalene [by -3.8(-6.4- -1.2) nmol/s and -6.6(-8.2- -5.1)%], intercostal [by -1.4(-90 
2.4- -0.4) nmol/s and -6.0(-8.6- -3.3)%] and abdominal muscles [by -1.9(-2.9- -0.8) nmol/s and 91 
-6.3(-9.1- -3.4)%] (p<0.001). The difference in respiratory (scalene and intercostal) muscle BFI 92 
between cycling and hyperpnoea was associated with greater dyspnoea (Borg CR10) scores (r= 93 
-0.54 and r= -0.49, respectively, p<0.05). These results suggest that in patients with COPD 1) 94 
locomotor muscle work during high-intensity exercise interferes with extradiaphragmatic 95 
respiratory muscle perfusion and that 2) insufficient adjustment in extradiaphragmatic 96 
respiratory muscle perfusion during high-intensity exercise may partly explain the increased 97 
sensations of dyspnoea.  98 
 99 
 100 
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The ability to measure respiratory muscle blood flow allows the investigation of a number of 114 
physiological and pathophysiological factors that limit exercise tolerance in healthy individuals 115 
and in patients with chronic cardiorespiratory diseases.  116 
However, traditional techniques for assessing respiratory muscle blood flow are highly 117 
invasive, exposing the individuals to unnecessary health risks (14). Near-Infrared Spectroscopy 118 
in conjunction with infusions in the circulation of the light-absorbing tracer indocyanine green 119 
dye, (NIRS-ICG technique) has been increasingly applied over the past decade to provide a less 120 
invasive and reliable method for assessing absolute and relative values (blood flow index) of 121 
local respiratory (and locomotor) muscle perfusion at rest and during exercise in healthy 122 
participants and in patients with Chronic Obstructive Pulmonary Disease (COPD) (14, 32, 33, 123 
36, 54).  124 
In this context, the theory of blood flow redistribution from the locomotor to respiratory 125 
muscles during high-intensity exercise (22, 23) is based on evidence in healthy and trained 126 
subjects showing a decrease in locomotor muscle blood flow when respiratory muscle work is 127 
artificially increased (and cardiac output is maximal), or an increase in locomotor muscle blood 128 
flow when respiratory muscle work is decreased (37, 38). Based on these findings, it has been 129 
postulated that owing to the high work of breathing sustained by patients with COPD during 130 
exercise, blood flow may increase in favor of the respiratory muscles, thereby compromising 131 
locomotor muscle blood flow (85).  132 
We have previously demonstrated that in patients with COPD, intercostal muscle blood flow 133 
progressively increased during voluntary hyperpnoea over a wide range of exercise ventilations 134 
up to maximal (85). However, during graded cycling, intercostal muscle blood flow fell 135 
progressively from rest  to the early stages of exercise, whilst cardiac output was rising. When 136 
cardiac output plateaued during high-intensity exercise (between 75%-100% of peak work), a 137 
greater fall in intercostal muscle perfusion occurred contrasting sharply with the respiratory 138 
muscle perfusion responses during voluntary hyperpnoea (85). Furthermore, when COPD 139 
patients breathed 21% oxygen in helium (i.e., Heliox) or 100% oxygen to reduce respiratory 140 
muscle load, there was no redistribution of blood flow between locomotor and respiratory 141 
muscles in either direction at or near peak exercise, thereby challenging the theory of blood 142 
flow redistribution between the locomotor and respiratory muscles (55, 83, 90). The 143 
aforementioned studies in COPD were, however, focused on the assessment of intercostal 144 
muscle blood flow acknowledging potential limitations such as partitioning of blood flow 145 
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between the intercostal muscles and the diaphragm and/or movement-related artefacts (76, 83). 154 
In addition, assessment of intercostal muscle blood flow alone may not necessarily reflect the 155 
global respiratory muscle perfusion requirements during exercise in this population (76, 83).  156 
Accordingly, the objective of this exploratory study was to investigate whether high-157 
intensity exercise interferes with respiratory muscle perfusion in patients with COPD. Due to 158 
the inability to assess diaphragm perfusion, we focused on assessing the blood flow index and 159 
oxygenation of other muscles of respiration namely scalene, intercostal and abdominal muscles 160 
during cycling and during voluntary normocapnic hyperpnoea sustained at comparable levels of 161 
minute ventilation and breathing pattern aiming to reproduce a comparable work of breathing 162 
(WoB). We also assessed key variables such as central hemodynamic responses, diaphragmatic 163 
and extradiaphragmatic respiratory muscle activation, and locomotor muscle perfusion during 164 
both experimental conditions. We hypothesized that if at the same WoB the intercostal, scalene 165 
and abdominal muscle blood flow index were lower during cycling compared to hyperpnoea, 166 
this would suggest that high-intensity exercise interferes with respiratory muscle perfusion in 167 
patients with COPD. 168 
 169 
Methods 170 
Study group 171 
Eighteen clinically stable patients with COPD (FEV1: 58 ± 24% predicted) according to the 172 
Global Initiative for Chronic Obstructive Lung Diseases (GOLD) participated in the study. 173 
Exclusion criteria included no participation in exercise-training programs in the year before, no 174 
long-term oxygen use and not presenting cardiovascular conditions limiting exercise tolerance, 175 
severe orthopaedic conditions, psychiatric or cognitive disorders and/or progressive 176 
neurological or neuromuscular disorders. 177 
Study design 178 
The Ethical Committee Research of KU Leuven/UZ Leuven, Belgium approved the study 179 
(protocol ID: S58513). Prior to patient enrolment into the study, associated risks and potential 180 
benefits of participation were explained, and patients provided their written informed consent. 181 
The study conformed to the standards set by the Declaration of Helsinki and has been 182 
registered to a database (ClinicalTrials.gov, Identifier: NCT03240640). The study is part of a 183 
broader Randomized Clinical Trial (RCT) aiming to investigate the effects of Inspiratory 184 
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Muscle Training, by Tapered Flow Resistive Loading on the shortness of breath and on 189 
postural control (Clinical Trial Identifier: NCT03240640). Data in Table 1 (baseline 190 
characteristics) and Tables 2-6 in 16 out of 18 patients obtained during rest and hyperpnoea 191 
have appeared in a recent publication of our group (73), whilst data recorded during cycling 192 
have not appeared anywhere in that, or in any other, report.  193 
Preliminary assessments  194 
All patients underwent the following preliminary assessments prior to visit 1: 195 
anthropometrics, pulmonary function (61, 89) and functional capacity (six-minute walking 196 
distance test and physical activity assessments). The six-minute walking distance test was 197 
performed according to the ATS guidelines (8). Physical activity in terms of steps per day was 198 
assessed by a validated for patients with COPD activity monitor (68, 71) using standardized 199 
methodology (21). 200 
Experimental design 201 
Experiments were conducted in 3 visits (Figure 1). During visit 1, patients performed 202 
assessment of respiratory muscle strength (46) and a symptom-limited cardiopulmonary 203 
exercise test on an electromagnetically braked cycle ergometer to determine peak work rate 204 
(WRpeak) (70).  205 
During visit 2 (>48 hours after visit 1) patients underwent a constant-load cycling test at 206 
80% WRpeak to the limit of tolerance (i.e., exercise duration 366 ±109 sec) aiming to record 207 
the ventilatory responses (i.e., mean tidal volume, breathing frequency and minute ventilation) 208 
that patients were requested to reproduce during the hyperpnoea trial on visit 3 (see below). 209 
The limit of exercise tolerance was defined as the time point at which patients signalled the 210 
inability to continue exercising or could not maintain the required pedalling rate (50 – 60 211 
revolution/min) despite being encouraged by the investigators to carry on cycling. Before and 212 
after the constant-load cycling test, assessment of isometric quadriceps strength and quadriceps 213 
muscle contractile fatigue (Magstim Co Ltd, Whitland, UK) were performed (16).  214 
During visit 3 (>48 hours after visit 2) patients initially performed a voluntary normocapnic 215 
hyperpnoea trial reproducing the ventilatory responses (i.e., mean tidal volume, breathing 216 
frequency and minute ventilation) recorded for each patient during the last 3 minutes of the 217 
constant-load exercise test performed during visit 2. Patients were seated on a chair, with bent 218 
knees (at an angle approximately 90°), and the back of the trunk was straight without been 219 
supported by the back of the chair, whilst both arms were extended forward with the palms 220 
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touching the knees.Hyperpnoea was sustained to the point patients could not maintain 223 
ventilatory responses to levels comparable to those during exercise. During the hyperpnoea test 224 
investigators provided continuous verbal guidance aiming to ensure a maximum variation in 225 
minute ventilation less than 5% throughout the test. This was facilitated by visual feedback on 226 
breathing parameters that was provided real-time on a screen monitor (73). Normocapnia was 227 
maintained by having subjects inspire from a Douglas bag containing 5% CO2, 21% O2 and 228 
74% N2, connected to a two-way non-rebreathing valve (model 2700, Hans Rudolph) by a 229 
piece of tubing (85, 86). Following a sufficient resting period [average 27 min (range: 25-31 230 
min)], patients performed a constant-load cycling test at 80% WRpeak to the limit of tolerance. 231 
During hyperpnoea and constant-load exercise, recordings of pulmonary gas exchange and 232 
ventilatory variables were performed breath-by-breath (Vmax 229; Sensor Medics, San Diego, 233 
CA). Arterial oxygen saturation was measured continuously by a pulse oximeter and blood 234 
pressure was assessed every minute by an automated cuff monitor integrated to the cycle 235 
ergometer. Breathlessness and leg discomfort were measured by the modified Borg scale (11). 236 
During cycling, patients performed inspiratory capacity (IC) manoeuvres every two minutes to 237 
identify the degree of dynamic lung hyperinflation assuming constant total lung capacity (TLC) 238 
(64). 239 
Subject preparation 240 
Subjects were prepared first with a combined EMG diaphragm-electrode catheter with 241 
oesophageal and gastric balloons that were inserted nasally after topical anesthesia for the 242 
assessment of activation of the diaphragm (EMG), as well as oesophageal (Pes) and gastric 243 
(Pga) pressure measurements. Seven out of the eighteen (n=7/18) patients refused to undergo 244 
measurements of diaphragm EMG, Pes and Pga with the oesophageal catheter system. Thus, 245 
data on diaphragmatic activation, respiratory pressures and work of breathing represents 11 out 246 
of 18 patients. There were no significant differences in physiological responses during cycling 247 
and hyperpnoea between patients with diaphragm EMG and respiratory pressures 248 
measurements (n=11, male: n=7 and female: n=4) compared to those without these 249 
measurements (n=7, male: n=4 and female: n=3). Subjects were prepared with a venous 250 
catheter (Insyte Autoguard BC Winged, 22GA, 0.9 x 25mm) for the measurement of the 251 
respiratory and locomotor muscle blood flow index. Using a sterile technique, the catheter was 252 
introduced percutaneously into the right or left antecubital forearm vein, oriented in the 253 
proximal direction. The catheter was used to inject a bolus of ICG, while it was kept patent 254 
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throughout the experiment by periodic flushing with saline. One patient did not have 258 
respiratory muscle perfusion measures due to contraindications regarding ICG injections. 259 
Respiratory muscle pressures and work of breathing  260 
The oesophageal/gastric balloon catheter was used for the assessment of Pes, Pga, 261 
transdiaphragmatic pressure (Pdi=Pga-Pes) and diaphragm EMG activation via five diaphragm 262 
electromyography electrode pairs (Yinghui Medical Equipment Technology Co. Ltd., 263 
Guangzhou, China). After optimal placement (20, 45, 58), the catheter was secured at the 264 
patient´s nose with tape. The diaphragm EMG signals were sampled at 2000 Hz (Micro1401-3, 265 
Cambridge Electronic Design Limited, Cambridge, UK), amplified (Biomedical amplifier, 266 
Guangzhou, China) and then recorded and processed by a data acquisition software (Spike 2, 267 
Cambridge Electronic Design Limited, Cambridge, UK). Diaphragm EMG data were converted 268 
into root mean square (RMS) and were expressed as percentages of maximum activation 269 
(diaphragm EMG, %max) that was recorded during IC maneuvers (i.e., obtained at rest or 270 
during exercise, 20, 73). Respiratory flow signals, Pes and Pga signals were continuously 271 
sampled at 100 Hz (Micro1401-3, Cambridge Electronic Design Limited, Cambridge, UK), and 272 
then recorded and processed by the same data acquisition software (Spike 2, Cambridge 273 
Electronic Design Limited, Cambridge, UK). Maximal Pes and Pdi pressures were measured 274 
from FRC during sniff maneuvers, and maximal Pga was measured from TLC during forced 275 
expiratory capacity maneuvers. Pes, Pga and Pdi were expressed as percentages of maximal 276 
activation and were used as indices of global inspiratory, expiratory and diaphragmatic effort, 277 
respectively (45). Pes, Pga, Pdi and WoB over one-minute periods was calculated by 278 
integrating volume and pressure generated (e.g., Pes WoB= Pes x tidal volume), then 279 
multiplied by breathing frequency (e.g., Pes WoB/min= Pes WoB x bf) and presented in 280 
L/cmH2O/min. Pes, Pga and Pdi Pressure-Time Products (PTP) – commonly considered indices 281 
of the energy of breathing (46) – were assessed by multiplying each of the pressures by the 282 
time of muscle contraction and breathing frequency and presented in cmH2O/sec/min. 283 
Respiratory muscle activation 284 
Respiratory muscles activation, for scalene [(sca), left posterior triangle of the neck], 285 
sternocleidomastoid [(scm), midpoint along the long axis of the right sternocleidomastoid 286 
muscle], parasternal intercostal [(picm), right parasternal space of the 2nd and 3rd rib 3 cm 287 
lateral to the sternum], 7th intercostal [(7thicm), midaxillary line, right 7th intercostal space], 288 
rectus abdominis [(abd), upper right 1/3 of rectus abdominis below the costal cartilage] and 289 
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vastus lateralis [(vl), left vastus lateralis muscle 10-12 cm above the knee] was measured by 290 
surface electromyography (EMG) (Desktop Direct Transmission (DTS), NORAXON, 291 
Scottsdale, USA) (73), sampled at 2000 Hz (Micro1401-3, Cambridge Electronic Design 292 
Limited, Cambridge, UK), and then recorded and processed by a data acquisition software 293 
(Spike 2, Cambridge Electronic Design Limited, Cambridge, UK). For EMGsca, EMGscm, 294 
EMGpicm, EMG7thicm data were expressed as percentages of maximum activation during IC 295 
maneuvers (i.e., obtained at rest or during exercise, 20, 73) and for EMGabd data were 296 
expressed as percentages of maximum activation during forced expiratory capacity maneuvers 297 
(73). EMGvl data of maximum activation were recorded during a maximal voluntary isometric 298 
contraction of the knee extensors (40). All ventilatory and respiratory pressures, WoB, 299 
respiratory and locomotor muscle activation signals used for comparisons at rest, during 300 
hyperpnoea and cycling were the average of all values recorded over the last 60 seconds at rest 301 
and during the last 30 seconds of hyperpnoea and cycling. 302 
Central hemodynamic responses  303 
Cardiac output was measured continuously during hyperpnoea and cycling by an impedance 304 
cardiography device (PhysioFlow PF05; Manatec Biomedical, Macheren, France, PhysioFlow). 305 
Six electrodes were placed according to the manufacturers´ instructions (53). Data points were 306 
excluded when signal quality was less than 90% (53). Cardiac output values were recorded at 307 
1-second intervals and were the average over the last 60 seconds during rest and during the last 308 
30 seconds of hyperpnoea and cycling trials. Systemic oxygen delivery was calculated as the 309 
product of cardiac output and arterial oxygen content; the latter was calculated using the 310 
following formula: [1.39 x hemoglobin concentration [Hb] x %SpO2] (12). Arterio-venous 311 
oxygen content (a-vO2) difference was calculated by dividing whole-body oxygen uptake by 312 
cardiac output (73). The oxygen extraction ratio was calculated as the ratio of the arteriovenous 313 
oxygen content (a-vO2) difference to arterial oxygen content and expressed in percentage. 314 
Systemic vascular conductance was calculated by dividing cardiac output by the mean arterial 315 
blood pressure (73). 316 
 317 
 318 
Muscle blood flow index by NIRS 319 
To measure respiratory and vastus lateralis muscle blood flow index (BFI), we used the 320 
NIRS-ICG derived BFI method (32, 36, 54). Specifically, four sets of NIRS probes from two 321 
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commercial Near-Infrared Spectroscopy (NIRS, Continuous Wave, Spatially Resolved 322 
Technique, NIRO-200 and a NIRO-200NX; HAMAMATSU Photonics KK) devices were used 323 
in combination with the light-absorbing indocyanine green dye (ICG). The four NIRS probes 324 
were placed at scalene (right posterior triangle of the neck), 7th intercostal (midaxillary line, left 325 
7th intercostal space) and rectus abdominis (upper left 1/3 of rectus abdominis below the costal 326 
cartilage) muscles (73). The fourth NIRS probe was placed over the left vastus lateralis muscle 327 
10-12 cm above the knee (next to EMG electrode) (86). NIRS-ICG derived BFI was calculated 328 
by dividing the ICG peak concentration of the muscle by the rise time from 10 to 90% of peak 329 
according to established methods and expressed in nanomoles/sec (nmol/sec) (32, 36, 54, 73). 330 
In addition, BFI data were adjusted for resting values and expressed as fold change from rest 331 
during cycling and hyperpnoea (54). ICG injections for calculating BFI were performed at rest 332 
and during the last 30 seconds of hyperpnoea and cycling trials. ICG concentration curves data 333 
were exported by NIRS in document file format (i.e., filename extension ´txt´) and stored on 334 
disk for off-line analysis. ICG concentration curves in ´txt´ format were analyzed by using the 335 
Chart5 version 5.4.2 (ADInstruments) program. Low-pass filtering with a cutoff frequency of 336 
0.5 Hz and smoothing window width (by using the triangular Bartlett window function) of nine 337 
points produced the smoothed curve that was used for BFI calculation (36, 54, 73). 338 
Muscle oxygenation by NIRS 339 
For respiratory and vastus lateralis muscle oxygenation, the same NIRS devices were used. 340 
Concentration changes in deoxy (Hb+Mb) were used as an index of muscles oxygen extraction 341 
and total (Hb+Mb) as an index of blood volume reflecting changes in microvascular 342 
conductance (vasodilation or vasoconstriction responses) for respiratory and vastus lateralis 343 
muscles (31). In addition, absolute values of NIRS derived fractional tissue O2 saturation index 344 
(%StiO2; i.e., the ratio of [oxy(Hb+Mb)] to [total(Hb+Mb)] expressed as a fraction 345 
([oxy(Hb+Mb)]/[total(Hb+Mb)]*100) that reflect the tissue capacity to match oxygen supply 346 
relative to its metabolic demand (31, 52, 84) were also recorded. A path length of 18.6 cm was 347 
set up for all respiratory and vastus lateralis muscles. Separation distance between the NIRS 348 
light transmitter and receiver probes was 40 mm, thus allowing a maximum NIRS penetration 349 
depth of 20 mm. NIRS oxygenation data were sampled at 5 or 6 Hz and averaged during the 350 
last 60 seconds at rest and during the last 30 seconds for hyperpnoea and cycling. Adipose 351 
tissue thickness (fat + skin layer) were performed by a Harpenden 10-skinfold caliper on the 352 
scalene, 7th intercostal space, rectus abdominis and the vastus lateralis muscle (80). The mean 353 
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values (±SD) of the 18 subjects of the adipose tissue for scalene, intercostal, abdominal and 356 
vastus lateralis muscles were  3.4 ± 1.6 mm, 8.6 ± 3.8  mm,  11.5 ± 5.0  mm and 7.5 ± 4.4  mm, 357 
respectively.  358 
Assessment of quadriceps muscle strength and fatigue  359 
 Patients were sitting in a recumbent chair (hips extended at 120° and knees flexed at 90°) 360 
with arms crossed in front of the chest (16) for the assessment (right leg) of unpotentiated 361 
quadriceps twitch contractions (at 30, 50, 70, 80, 90, 95 and 100% of the maximum stimulator 362 
output), maximal voluntary contractions (five isometric MVC for 3 sec) and potentiated 363 
quadriceps twitch contractions (five contractions with a twitch at 100% of the power output of 364 
the stimulator) before, 10 and 35 min after the constant-load cycle exercise (5). The strain-365 
gauge signal was transformed by an analogue force transducer (546QD; CDS Europe, Milan, 366 
Italy), amplified (Biopac mp150; Biopac Systems, Goleta, CA, USA) and then processed with a 367 
specific data acquisition and analysis program (AcqKnowledge Software, Biopac Systems, 368 
Goleta, CA, USA). The highest values recorded during MVC and during potentiated quadriceps 369 
twitch contractions was included in the analysis and expressed in predicted values (3, 74). A 370 
fall in potentiated quadriceps twitch contractions of ≥15%, 10 min after exercise was 371 
considered as a sign of significant contractile fatigue (16, 74). 372 
Statistical analysis 373 
Data are expressed as mean ± SD at rest, cycling and hyperpnoea or as mean difference with 374 
95% confidence interval (lower and upper limit) for comparisons between the three conditions 375 
(i.e., at rest, cycling and hyperpnoea). The normality of all the data was examined by the 376 
Shapiro-Wilk test. Ventilatory and breathing pattern parameters, respiratory muscle pressures 377 
and WoB, respiratory and locomotor muscle activation, central hemodynamic and respiratory 378 
and locomotor blood flow and oxygenation variables recorded at rest, during hyperpnoea, and 379 
cycling were compared using repeated-measures ANOVA or by the Friedman test when normal 380 
distribution was violated. When ANOVA (or Friedman test) detected significant differences 381 
between rest, hyperpnoea, and cycling, pairwise comparisons with Bonferroni correction (for 382 
ANOVA) or using Dunn´s Multiple Comparison Test (for Friedman test) were performed as 383 
pos-hoc analysis. Changes from rest in respiratory and vastus lateralis muscle BFI and 384 
oxygenation variables between cycling and hyperpnoea tests were compared by paired t-tests 385 
when normally distributed, or by Wilcoxon signed-rank tests if normal distribution assumptions 386 
were not met. Changes in respiratory and vastus lateralis muscle BFI and oxygenation variables 387 
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between cycling and hyperpnoea tests among patients with different stages of diseases severity 388 
were compared by unpaired t-tests when normally distributed, or by Welch's Test if normal 389 
distribution assumptions were not met. Pearson´s correlation coefficient (r) was used to 390 
establish associations between BFI (expressed as the difference between cycling and 391 
hyperpnoea) and dyspnoea (expressed as the difference between cycling and hyperpnoea) for 392 
intercostal, scalene, rectus abdominis, and vastus lateralis muscles. The minimum sample size 393 
was calculated based on 80% power and a two-sided 0.05 significance level. An expected effect 394 
size [Cohens d] of 0.497 was calculated based on data from a previous study in patients with 395 
COPD (FEV1: 51±18%predicted) (85), which demonstrated a significant decrease in intercostal 396 
muscle %StiO2 during cycling compared to voluntary normocapnic hyperpnoea. Specifically, 397 
that study (85) revealed a mean difference in intercostal muscle %StiO2 of -2.00% with a 398 
corresponding pooled SD of 4.02% between cycling (at 75% of peak work rate, ~60 watts) and 399 
hyperpnoea sustained at levels of minute ventilation similar to those recorded during cycling 400 
(~45 litres/min). The critical sample size was calculated to be 9 patients using repeated-401 
measures ANOVA as the primary statistical analysis method. Taking into consideration the 402 
challenges imposed on patients by the invasive procedures, we decided to recruit 18 patients for 403 
obtaining a full dataset for the minimum required number of patients. Data were analyzed using 404 
the GraphPad Prism statistical software. The level of significance was set at p<0.05. 405 
 406 
Results 407 
Subject characteristics. 408 
Subject characteristics are shown in Table 1. Five patients were Global Initiative for COPD 409 
(GOLD) stage I, seven patients were GOLD stage II, five patients were GOLD stage III and 410 
one patient was GOLD stage IV. Patients demonstrated decreased exercise and functional 411 
capacity and inspiratory muscle strength and mildly reduced physical activity levels (77) 412 
indicated by the physical activity measures (Table 1).  413 
Breathing pattern, symptoms and locomotor muscle fatigue  414 
Tidal volume, breathing frequency, and duty cycle did not differ between hyperpnoea and 415 
cycling sustained at comparable levels of minute ventilation (p>0.1 for all comparisons, Table 416 
2). Peak inspiratory flows did not differ between the two conditions (p=0.97). During cycling 417 
patients demonstrated a significant reduction from rest in inspiratory capacity (p<0.0001, Table 418 
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2). Specifically, the decrease from rest in inspiratory capacity during cycling did not 421 
significantly differ among patients with different stages of disease severity (GOLD I: -0.394 ± -422 
0.407, GOLD II: -0.441 ± -0.480, GOLD III-IV: -0.493 ± -0.395 L, p>0.1). Dyspnoea at end of 423 
cycling was significantly higher compared to hyperpnoea (p=0.0008, Table 2). Leg discomfort 424 
at end of cycling was 7.0 ± 2.8 on the 10-Borg scale. The primary reason for stopping cycling 425 
was dyspnoea (n=7), leg discomfort alone (n=4) and the combination of both leg discomfort 426 
and dyspnoea (n=7). Compared to resting values of potentiated quadriceps twitch contraction 427 
force (11.5 ± 4.3 kg), this was significantly decreased on average by 22 ± 21% and 23 ± 17%, 428 
10 and 35 min after the end of the constant-load exercise test (visit 2), respectively (10 min: 9.2 429 
± 4.5 kg and 40 min: 9.1 ± 4.2 kg, both p<0.001). 430 
Respiratory pressures and work of breathing   431 
Pes, Pdi and expiratory Pga significantly increased from rest during both hyperpnoea and 432 
cycling trials (p<0.0001 for all comparisons) (Table 2). No significant differences in Pes, Pdi 433 
and expiratory Pga were observed between the two conditions (p>0.1 for all 434 
comparisons). Inspiratory WoB (both Pes and Pdi) significantly increased from rest during both 435 
hyperpnoea and cycling trials (p<0.0001 for all comparisons) but we did not observe any 436 
significant differences between the two conditions (p=0.44 and p=0.24, respectively) (Table 2). 437 
Expiratory WoB (Pga) significantly increased from rest only during hyperpnoea (p=0.002). 438 
However, no significant differences in expiratory WoB were found between hyperpnoea and 439 
cycling (p=0.51) (Table 2). The pressure-time products (PTP) of Pes and Pdi significantly 440 
increased from rest during both hyperpnoea and cycling (p<0.0001 for all comparisons), 441 
whereas no significant differences were found between the two conditions (p=0.35 and p=0.93, 442 
respectively) (Table 2). PTP of expiratory gastric pressure significantly increased from rest 443 
during both hyperpnoea and cycling (p=0.001 and p=0.003, respectively) and tended to be 444 
significantly greater during hyperpnoea compared to cycling (p=0.083) (Table 2). 445 
 446 
 447 
Activation of respiratory and locomotor muscles 448 
Activation of all respiratory muscles significantly increased from rest during hyperpnoea 449 
and cycling (p<0.0001 for all comparisons) (Table 3). Furthermore, only sternocleidomastoid 450 
muscle activation was found to be significantly greater during hyperpnoea compared to cycling 451 
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(p=0.005). As expected, vastus lateralis muscle activation significantly increased from rest 452 
(p=0.0005) and was significantly greater during cycling compared to hyperpnoea (p=0.009). 453 
Central hemodynamic and metabolic responses  454 
Heart rate, stroke volume, cardiac output, and oxygen consumption significantly increased 455 
from rest during hyperpnoea and cycling (p<0.0001 for all comparisons) and were significantly 456 
greater during cycling compared to hyperpnoea (p=0.001-0.0001) (Table 4). Furthermore, 457 
arterial oxygen saturation significantly decreased from rest during cycling (p=0.0007) and was 458 
significantly lower compared to hyperpnoea (p=0.0018) (Table 4). Systemic oxygen delivery, 459 
systemic arteriovenous oxygen content difference and oxygen extraction were significantly 460 
greater during cycling compared to hyperpnoea (p=0.0001- p=0.0033, Table 4). Mean arterial 461 
blood pressure and systemic vascular conductance were significantly increased from rest during 462 
hyperpnoea (p=0.006, p=0.009, respectively) and cycling (p=0.0001, p<0.0001, respectively) 463 
and were greater during cycling compared to hyperpnoea (p=0.0012, p<0.0001, respectively) 464 
(Table 4).  465 
Perfusion responses of respiratory and locomotor muscles 466 
During cycling, vastus lateralis muscle BFI significantly increased from rest (p=0.0005) and 467 
was greater compared to hyperpnoea (p=0.0005, Figure 2 D and Table 5). However, scalene 468 
(p=0.74), 7th intercostal (p=0.072) and abdominal muscle BFI (p=0.093) did not significantly 469 
differ from resting levels (Figure 2 A, B and C and Table 5). Moreover, during cycling scalene 470 
(p=0.0018), intercostal (p=0.0039) and abdominal (p=0.0045) muscle BFI was significantly 471 
lower compared to hyperpnoea (Figure 2 A, B and C and Table 5). Similarly, when BFI values 472 
were expressed as fold changes from rest, vastus lateralis muscle BFI during cycling was 473 
significantly greater (p=0.001), whilst scalene (p=0.0003), intercostal (p=0.0017) and 474 
abdominal (p=0.023) muscle BFI were significantly lower compare to hyperpnoea (Figure 3 A, 475 
B and C). In addition, the pattern of change in respiratory muscle BFI (i.e., decrease) and leg 476 
muscle BFI (i.e., increase) to cycling versus hyperpnoea was the same across different stages of 477 
COPD severity (Table 6).  478 
 479 
Oxygenation responses of respiratory and locomotor muscles 480 
During hyperpnoea, total [Hb+Mb] concentration increased from rest in scalene (p=0.0027), 481 
7th intercostal (p=0.079) and abdominal (p=0.028) muscles (Table 5). In addition, during 482 
hyperpnoea, total [Hb+Mb] concentration was greater for the scalene (p=0.0061), 7th intercostal 483 
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(p=0.054) and abdominal (p=0.033) muscles compared to cycling (Table 5). During cycling, 484 
deoxy [Hb+Mb] concentration significantly increased from rest in intercostal (p=0.009), 485 
abdominal (p=0.0027) and vastus lateralis muscle (p=0.0042) and it was found to be 486 
significantly greater for the 7th intercostal (p=0.0006) and abdominal muscles (p=0.0011) 487 
compared to hyperpnoea (Table 5). During hyperpnoea, scalene, 7th intercostal, abdominal and 488 
vastus lateralis muscle %StiO2 was not different compared to that recorded at rest (p>0.05, 489 
Figure 4 and Table 5). In contrast, during cycling, a significant reduction from rest in %StiO2 490 
was observed in scalene (p<0.0001), 7th intercostal (p=0.0015), abdominal (p<0.0001) and 491 
vastus lateralis muscle (p=0.0013) (Figure 4 and Table 5). Furthermore, scalene (p<0.0001), 7th 492 
intercostal (p=0.0002) abdominal (p<0.0001) and vastus lateralis muscle (p=0.0009) %StiO2 493 
was significantly lower during cycling compared to hyperpnoea (Figure 4 and Table 5). In 494 
addition, no significant differences were found in respiratory and leg muscles %StiO2 to 495 
cycling versus hyperpnoea across different stages of COPD severity (Table 6). 496 
Associations between muscle activation, perfusion and dyspnoea during cycling and 497 
hyperpnoea  498 
We found significant inverse relationships between the reduction in the BFI of scalene and 499 
7th intercostal muscles and the greater dyspnoea scores in cycling compared to hyperpnoea (r=-500 
0.54, p=0.026 and r=-0.49, p=0.043, respectively ). No significant relationships were found for 501 
abdominal and vastus lateralis muscle BFI and dyspnoea scores (r=-0.32, p=0.020 and r=0.05, 502 
p=0.83, respectively ). In addition, no significant relationships were found amongst differences 503 
in activation of diaphragm, scalene, parasternal, 7th intercostal and abdominal muscles and the 504 
differences in dyspnoea scores between cycling and hyperpnoea trial (p>0.1). Finally, no 505 
significant relationships were found between differences in activation of scalene, 7th intercostal 506 
and abdominal muscles and differences in their perfusion between cycling and hyperpnoea 507 




Main findings 512 
The main findings of the present study in patients with COPD are as follows. 1) During 513 
hyperpnoea, when locomotor muscles did not compete with the respiratory muscles for the 514 
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available blood flow, intercostal, scalene, and abdominal local muscle perfusion was 517 
significantly increased from rest (Figure 2 and 3, and Table 5). However, during high-intensity 518 
exercise (i.e., 80% WRpeak), intercostal, scalene, and abdominal local muscle perfusion did not 519 
increase from rest (Figure 2 and 3, and Table 5) whilst cardiac output reached peak values 520 
(Tables 1 and 4). 2) Intercostal, scalene, and abdominal muscle oxygen extraction (inferred by 521 
deoxy [Hb+Mb]) was greater and microvascular conductance (inferred by total [Hb+Mb]) and 522 
oxygen saturation (%StiO2) were lower during cycling compared to hyperpnoea (Figure 4 and 523 
Table 5). 3) Lack of increase from resting levels in respiratory muscle perfusion during 524 
exercise compared to hyperpnoea occurred at comparable levels of respiratory muscle 525 
activation and work of breathing (Table 3) and it was associated with greater dyspnoea 526 
sensations. Collectively, these results suggest that high-intensity  exercise interferes with 527 
extradiaphragmatic respiratory muscle perfusion and that limitations in extradiaphragmatic 528 
respiratory muscle perfusion during cycling may, in part, explain the increased dyspnoea 529 
sensation in exercising patients with COPD. 530 
Mechanisms of insufficient adjustments in respiratory muscle perfusion during cycling  531 
We considered several factors that might be singly or jointly responsible for the insufficient 532 
adjustments in extradiaphragmatic respiratory muscle perfusion during cycling. First, patients 533 
across different stages of disease severity (35), exhibited a profound degree of dynamic lung 534 
hyperinflation during cycling which may have, in turn, hindered the normal increase in cardiac 535 
output (Table 2). Indeed, heart compression and intrathoracic hypovolemia consequent to 536 
exercise-induced dynamic hyperinflation, have been postulated to impede the normal increase 537 
in cardiac output (4, 51, 82) whilst reductions in dynamic lung hyperinflation by 538 
bronchodilators or Heliox administration have been shown to improve cardiac function during 539 
high-intensity  exercise in patients with COPD (46, 47, 55, 87). Under these circumstances the 540 
circulatory system may be unable to meet the demands of the respiratory muscles during 541 
cycling requiring greater muscle oxygen extraction (85).  Indeed, we found that for a 542 
comparable work of breathing between hyperpnoea and cycling, insufficient respiratory muscle 543 
blood flow (Figure 2 and 3, Table 5 and 6) during cycling was associated with greater 544 
respiratory muscle oxygen extraction as this was inferred by a greater increase in deoxy 545 
[Hb+Mb] compared to hyperpnoea. 546 
Secondly, a potential mechanical impediment to extradiaphragmatic respiratory muscle 547 
perfusion might be due to intense muscle contraction and the development of high 548 
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intramuscular pressures (19, 50, 75). Actually, the decrease in the operational capacity and 564 
potential deformation of vessels (squeezing or extension) within the inspiratory muscles 565 
resulting from the elevation of the ribs and sternum due to dynamic lung hyperinflation and/or 566 
strong recruitment of the abdominal muscles in the face of expiratory flow limitation may 567 
compromise extradiaphragmatic respiratory muscle perfusion (54, 55, 57, 60, 87, 90). In 568 
support of this mechanism, we previously demonstrated in patients with COPD that a reduction 569 
in dynamic lung hyperinflation and inspiratory and expiratory pressures during cycling by 570 
Heliox administration lead to an increase in both intercostal and abdominal muscle blood flow 571 
compared to room air breathing (55, 87).  572 
Thirdly, an increased sympathetic vasoconstrictor outflow to the respiratory muscles upon 573 
activation of the respiratory muscle metaboreflex may also provide a possible explanation for 574 
the insufficient adjustment in respiratory muscle perfusion during cycling (76). In this context, 575 
recently, it was suggested that muscle contractions of the respiratory muscles during high-576 
intensity  exercise can cause increased group III and IV afferent activity leading to a 577 
sympathetically mediated vasoconstriction, thereby contributing to limitations in respiratory 578 
muscle blood flow and O2 transport (76). The proposed greater development of intramuscular 579 
pressures and increased sympathetically mediated vasoconstriction to the respiratory muscles 580 
during cycling compared to hyperpnoea are supported by the findings (Table 5) showing lower 581 
microvascular conductance, inferred by lower total [Hb+Mb] during cycling compared to 582 
hyperpnoea, for all measured by NIRS extradiaphragmatic respiratory muscles. Therefore, the 583 
results of the present study do not provide evidence that insufficient adjustment in respiratory 584 
muscle perfusion during exercise is attributed to blood flow redistribution from the respiratory 585 
to the locomotor muscles but support the notion that central hemodynamic and local muscle 586 
mechanical impairments may contribute to the impediment of respiratory muscle perfusion 587 
during exercise in patients with COPD. 588 
Association between respiratory muscle perfusion and dyspnoea 589 
We found that at comparable levels of global respiratory muscle work, dyspnoea sensations 590 
were significantly greater during cycling compared to hyperpnoea (Tables 2 and 3). 591 
Furthermore, we demonstrated that the lower respiratory (intercostal and scalene) muscle BFI 592 
during cycling compared to hyperpnoea was associated with greater dyspnoea sensations 593 
during cycling . A potential explanation is that the lower local respiratory muscle BFI and 594 
microvascular oxygen supply during cycling compared to hyperpnoea would be expected to 595 
Zafeiris Louvaris  2/10/20 12:39
Deleted: 6596 
Zafeiris Louvaris  2/10/20 12:39
Deleted: 89597 
Zafeiris Louvaris  2/10/20 12:39
Deleted: 6598 
Zafeiris Louvaris  2/10/20 11:53
Deleted: strenuous599 
Zafeiris Louvaris  2/10/20 12:09
Deleted: (Figure 5)600 
18 
 
increase respiratory muscle metabolic acidosis and sensory afferent traffic in type III-IV fibres 601 
(innervating respiratory muscles) to the somatosensory cortex, thereby increasing the sensory 602 
intensity of unsatisfied inspiration during the cycling trial (49, 65, 66). Our findings are in line 603 
with previous and more recent studies in healthy individuals and in patients with chronic 604 
diseases (39, 41, 88) showing that skeletal muscle fatigue resistance is closely coupled with 605 
functional microvascular circulation for supporting adequate gas exchange, delivery of 606 
nutrients and removal of metabolites. Furthermore, our results corroborate with previous 607 
findings showing that improvements in intercostal and abdominal muscle oxygen delivery by 608 
Oxygen or Heliox supplementation are associated with reduced dyspnoea in patients with 609 
COPD (86, 54-57) (Table 2). However, part of the greater dyspnoea that patients demonstrated 610 
during cycling compared to hyperpnoea may be explained by ventilatory constraints (Table 2) 611 
and by the increase in peripheral locomotor muscle metabolic acidosis (leading to quadriceps 612 
muscle fatigue, see results section) and the greater sensory afferent traffic in type III-IV fibres 613 
to the somatosensory cortex as previously described by O´Donnell et al. (65, 66). Nevertheless, 614 
despite the association between diminished extradiaphragmatic respiratory muscle perfusion 615 
and greater dyspnoea levels, the mechanism(s) underlying this association remains not clear 616 
and future studies need to investigate the contributing role of impaired respiratory muscle 617 
perfusion during exercise on dyspnoea levels in these patients.Strength and methodological 618 
considerations 619 
Unique to our investigation is the simultaneous assessment of inspiratory, expiratory, and 620 
leg muscle perfusion whilst concomitantly assessing central haemodynamics and ensuring 621 
comparable work of breathing during hyperpnoea and exercise. Complementary to our study 622 
were the measures of the neural respiratory drive (diaphragm and extradiaphragmatic 623 
respiratory muscles activation by EMG) during hyperpnoea and cycling to better understand 624 
whether differences in respiratory muscle perfusion partly account for the greater dyspnoea 625 
levels during high-intensity exercise. To the best of our knowledge previous studies in patients 626 
with COPD focused on the perfusion of the 7th intercostal space, acknowledging the potential 627 
technical limitation of this site measurement (76, 83). We opted to investigate -besides 628 
intercostal muscles- the perfusion of the scalene muscle as it represents a superficial primary 629 
muscle of inspiration (27) with high activity at rest and during high-intensity  exercise in 630 
patients with COPD (25, 92). Furthermore, the abdominal muscles are the major muscles of 631 
expiration and are activated by patients with COPD even during quiet breathing (63), whereas 632 
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their efficiency is not affected as much by the occurrence of lung hyperinflation during exercise 639 
compared with the diaphragm (24).  640 
To avoid arterial cannulation we assessed relative muscle perfusion using the NIRS-derived 641 
BFI method (33, 36, 54). We observed that during cycling, four patients demonstrated a modest 642 
increase in BFI of vastus lateralis as their values fall outside the lower limits of confidence 643 
interval whilst two patients demonstrated a decrease in vastus lateralis BFI compared to rest 644 
(BFI responses of the six patients are marked with open symbols in Figure 3). Nevertheless, the 645 
insufficient increase in leg muscle BFI of these six patients was not associated with a 646 
concomitant increase in their respiratory muscle BFI, to support that in these patients high-647 
intensity exercise did not impair their extradiaphragmatic respiratory muscle perfusion (Figure 648 
3 A, B and C, open symbols). Furthermore, the large inter-subject variability observed in BFI of 649 
respiratory and vastus lateralis muscles (Figure 2) could be attributed to inter-subject variability 650 
in subcutaneous tissue, muscle vasculature and capillary density and/or in the large variation in 651 
work rate (range, min: 25 watts /max: 100 watts) and minute ventilation (range, min: ~12 652 
liters/min / max: ~71 liters/min) patients exhibited during the trials.  Therefore, the 653 
aforementioned parameters had to be taken into account when using the NIRS-ICG 654 
methodology for comparing BFI data on an individual level (36, 54). 655 
During cycling, patients exhibited moderate arterial oxygen desaturation (Table 4) that could 656 
have contributed to the greater respiratory (and locomotor) muscle hypoxemia compared to 657 
hyperpnoea (Table 5 and Figure 4). However, it is challenging to appreciate the effects of 658 
arterial hypoxemia on muscle perfusion and oxygenation responses during cycling compared to 659 
hyperpnoea for two reasons. First, this would have required an experimental condition where 660 
patients would cycle under hyperoxia (aiming to prevent arterial oxygen desaturation) and 661 
second, because during cycling cardiac output and systemic oxygen delivery were two-fold 662 
greater compared to hyperpnoea. 663 
In the present study, we employed a single bout of cycling corresponding to a high-intensity 664 
load (80%WRpeak) causing profound ventilatory, respiratory, and circulatory responses. Hence 665 
the physiological and symptom responses described in this context are pertinent only to high-666 
intensity, sustained exercise that is commonly adopted to assess the efficacy of 667 
pharmacological and non-pharmacological interventions in patients with COPD (69). However, 668 
the results of the present study may have limited external validity and practical significance 669 
during activities of daily living where it has been shown that the average energy requirement 670 
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corresponds to a moderate intensity of physical activity (i.e. approximately 50% of VO2peak , 683 
81). 684 
We deliberately chose non-invasive procedures for assessing central hemodynamic and 685 
respiratory and locomotor muscle oxygenation responses to cause minimal stress and pain to 686 
the patients and recognize the debate that exists in the literature for their absolute accuracy 687 
compared with gold standard methodologies (7, 12, 13, 31, 53, 54). Nevertheless, this study is 688 
based on a repeated-measures design, with the main purpose being to measure the same 689 
participants under different conditions (i.e., rest, hyperpnoea and cycling). Therefore, any 690 
systematic errors from the use of these non-invasive methodologies would not contribute to 691 
uncertainty in these repeated measures comparisons of the same group of patients. 692 
Study limitation 693 
The study could have been benefited from the inclusion of an elderly, age-matched healthy 694 
control group to determine whether the insufficient adjustment in respiratory muscle perfusion 695 
associated with greater dyspnoea levels during exercise was due to COPD, age, inactivity or 696 
other factors. However, as this study is part of a larger randomized clinical trial in patients with 697 
COPD, the recruitment of a healthy group was not feasible.  698 
We used continuous wave (CW) near-infrared spectrometers (spatial resolved spectroscopy 699 
[SRS], Hamamatsu photonics), where the light source is of constant intensity, and providing 700 
changes in superficial muscle haeme components from an arbitrary baseline (10). Recently 701 
more advanced near-infrared spectrometers incorporating time-domain technology can provide 702 
deeper muscle NIRS readings and absolute concentrations of the heme components in tissues of 703 
interest (10, 30, 43, 67). However, NIRS devices based on CW technology are the only 704 
commercial instruments with the capacity to simultaneously measure tissue haeme variables 705 
and ICG concentrations for the calculation of tissue perfusion.  706 
Due to limitations in the number of NIRS probes, measures were performed on a single 707 
muscle site for both respiratory and leg muscles acknowledging the substantial heterogeneity 708 
evident especially within the locomotor muscles (42, 44, 52, 84). Besides, we did not assess the 709 
reproducibility of the BFI measures during hyperpnoea and cycling assuming minimal variation 710 
due to steady state exercise (cycling and hyperpnoea) which in turn might cause insignificant 711 
variation in central hemodynamic, metabolic and ventilatory variables. In support of this, a 712 
recent study by Dominelli et al. (26), found reproducible BFI values (assessed by NIRS) in 713 
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both vastus lateralis and sternocleidomastoid muscles when ventilation, oxygen uptake, and 724 
WoB was consistent between repeated inspiratory muscle loading trials.  725 
Performing the hyperpnoea trial first and the cycling protocol afterwards (on the same day) 726 
may have influenced respiratory muscle oxygen delivery and uptake kinetic responses during 727 
the cycling test owing to muscle warm-up (1, 2, 15). However, the findings that before cycling, 728 
baseline values of heart rate (79±15 beats/min), cardiac output (5.5±1.4 litres/min) and %StiO2 729 
in scalene (68±9%), 7th intercostal (76±11%) and abdominal muscles (81±17%) did not differ 730 
compared to resting values (Figure 4 and Table 3 and 4, p>0.01) suggest that the time elapsed 731 
between the two protocols eliminated any effect of prior exercise on respiratory muscle blood 732 
flow regulation during cycling. Besides, patients´ dyspnoea sensations prior to the cycling test 733 
(0.9±1.0) returned to resting levels (Table 2, p>0.05). Inspiratory capacity manoeuvres for 734 
evaluating dynamic lung hyperinflation were not performed during hyperpnoea thereby 735 
enabling patients to better focus on reaching the targeted breathing pattern and minute 736 
ventilation  (34, 85, 86). However, whether dynamic lung hyperinflation, if any, compromised 737 
diaphragm and extradiaphragmatic respiratory muscle perfusion during hyperpnoea was not 738 
evaluated in the present study.  739 
Respiratory muscle pressures and work of breathing could not be measured in 7 out of 18 740 
patients. We argue that this limitation did not affect the findings of the present investigation. 741 
Similar studies in healthy individuals and in patients with COPD (85, 86) demonstrated that 742 
manipulation of the breathing pattern is sufficient to lead to similar respiratory muscle 743 
pressures and work of breathing between hyperpnoea and cycling trials as seen in this study. 744 
Finally, measures of respiratory muscle twitch force assessed by magnetic stimulation of 745 
phrenic nerves to evaluate potential respiratory muscle fatigue during cycling and hyperpnoea 746 
would have further strengthened our study. Clinical implications and future perspectives 747 
Randomised controlled trials in patients with COPD (17, 29, 45) have demonstrated that 748 
specific inspiratory muscle strength training (IMT) alone or as an adjunct intervention to an 749 
aerobic exercise training program may induce significant improvements in exercise capacity 750 
and dyspnoea sensations. Besides, evidence showing that implementation of high-intensity IMT 751 
in patients with chronic heart failure may improve the perfusion of exercising muscles (during 752 
upper limb muscle exercise) (18) potentially by attenuating the respiratory muscle 753 
metabaroreflex (91). In this context, studies in patients with COPD and in healthy individuals 754 
have shown an increase in the proportion of type I fibres and the size of type II fibres in the 755 
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external intercostal muscles along with improvements in respiratory muscle energy efficiency, 765 
following implementation of a high-intensity IMT intervention (72, 79). Furthermore, 766 
Rodrigues et al. (73) recently demonstrated that the stimuli imposed on the extradiaphragmatic 767 
muscles during high-intensity IMT by tapered flow resistive loading yielded a considerable 768 
increase in extradiaphragmatic muscle recruitment and metabolism, thus expecting substantial 769 
training adaptations to extradiaphragmatic muscles following several weeks of IMT. Yet, the 770 
effects of several weeks of IMT on perfusion, oxygenation, and activation pattern of 771 
extradiaphragmatic respiratory muscles during high-intensity  exercise remain unknown in 772 
patients with COPD (45). In addition, whether potential improvements in these physiological 773 
responses following IMT are associated with lower degrees of respiratory muscle fatigue and 774 
reduced dyspnoea sensations during whole-body exercise would be of specific interest to be 775 
investigated in patients with COPD.  776 
Conclusions 777 
The results of the present study suggest that in patients with COPD high-intensity  778 
locomotor muscle work during exercise interferes with extradiaphragmatic respiratory muscle 779 
perfusion despite a two-fold increase in cardiac output. Insufficient respiratory muscle 780 
perfusion during high-intensity exercise has a profound effect on extradiaphragmatic 781 
respiratory muscle oxygen availability and it is associated with greater dyspnoea sensations in 782 
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Table 1. Subjects characteristics, pulmonary function and peak exercise and 1230 
functional, quadriceps and respiratory muscle capacity data. 1231 
 1232 
Demographics / Anthropometrics 
Sex, male/female 10/8 
Age, years 66 ± 6 
BMI, kg/m2 27 ± 6 
Pulmonary function 
FEV1, L 1.4 ± 0.6 
FEV1, %pred. 58 ± 24 
FVC, L 3.2 ± 0.8 
FVC, %pred. 99 ± 30 
33 
 
FEV1/FVC, % 46 ± 13 
MVV, L/min 53 ± 16 
MVV, %pred. 68 ± 24 
TLC, L 6.5 ± 1.5 
TLC, %pred. 116 ± 20 
RV, L 3.4 ± 1.25 
RV, %pred. 151 ± 45 
RV/TLC, % 51 ± 10 
TLCO, mmol/min/kpa 4.2 ± 1.4 
TLCO, %pred. 55 ± 16 
SpO2 ,%                                                                                                                                             94  ±  1 
Hb, g/dl                                                                                        14.5 ± 1.3 
Peak exercise data  
Work rate, watts 79 ± 26 
Work rate, %pred. 70 ± 20 * 
VE, L 46 ± 14 
VE/MVV, % 87 ± 15 
Δ Insp. capacity, L -0.52 ± 0.36 
Tidal volume/ Insp. Capacity, % 78 ± 14 
VO2, L/min 1.3 ± 0.5 
34 
 
VO2,, %pred. 86 ± 31 
Heart rate, beats/min 120 ± 20 
Cardiac output, L/min 11.8 ± 2.3 
SpO2 ,%                                                                                                                                              88±4 
Dyspnoea,  10-Borg scale 7.2 ± 2.0 
Leg discomfort, 10-Borg scale 6.6 ± 2.0 
Functional, quadriceps and respiratory muscle capacity data 
6-minute walking test, meters. 496 ± 52 
6-minute walking test, %pred.  87 ± 12 ** 
Quadriceps muscle strength, kg  37 ± 10 
Quadriceps muscle strength, %pred.     81 ± 23 *** 
MIP, cmH2O 73 ± 15 
MIP, %pred       82 ± 21**** 
MEP, cmH2O 157  ±  12 
MEP, %pred  171 ± 12 **** 
Physical activity levels, steps per day 6663 ± 3618 
 1233 
Data are presented as mean ± SD for n=18 patients with COPD. FEV1: forced 1234 
expiratory volume in the first second; FVC: forced vital capacity; MVV: maximum 1235 
voluntary ventilation; TLC: total lung capacity; RV: residual volume; TLCO: transfer 1236 
factor for carbon monoxide; Hb: haemoglobin; VE: minute ventilation; Δ: changes in 1237 
inspiratory capacity from rest; VO2: oxygen consumption; SpO2: arterial oxygen 1238 
35 
 
saturation by pulse oximeter; MIP: maximal inspiratory pressure; MEP: maximal 1239 
inspiratory pressure.  Reference values calculated by:  1240 
*Blackie et al. 1989, **Troosters et al. 1999, ***Allaire et al. 2004, ****Neder et al. 1241 
19991242 
